ClinicalTrials.gov
public full text
Public Domain
Intravesical Ozone Therapy for Interstitial Cystitis/Bladder Pain Syndrome
This randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of intravesical ozone therapy in 60 patients with interstitial cystitis (IC). Participants were assigned to ozone therapy, placebo, or standard care groups for 3 weeks, with follow-up at 6 weeks. The primary outcome was the change in O'Leary-Sant ICSI score. Secondary outcomes included VAS pain score, SF-36 physical health, and urinary frequency.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone#884567
- Adverse Childhood Experiences in Urogynecologic Patients#848836
- Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)#1293140
- A Trial of Intravesical Therapy for Interstitial Cystitis in Patients With Generalized Vulvodynia#810408
- Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome#1073570
Record · ID 1497224
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive